Synthesis, molecular structure and anticancer activity of 1-allyl-3-amino-2-(4-chloro-2-mercaptobenzenesulphonyl)guanidine derivatives

被引:48
作者
Brzozowski, Z
Saczewski, F [1 ]
Gdaniec, M
机构
[1] Med Univ Gdansk, Dept Chem Technol Drugs, Gdansk, Poland
[2] Adam Mickiewicz Univ Poznan, Fac Chem, PL-60780 Poznan, Poland
关键词
1-allyl-3-amino-2-(2-mercaptobenzenesulphonl)guanidines; X-ray structure analysis; antitumour effect;
D O I
10.1016/S0223-5234(02)01341-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-allylamino-6-chloro-7-R-1.1-dioxo-1.4.2-benzodithiazines (2a-e) vas obtained by the reaction of 6-chloro-3-methylthio- 1.4.2-benzodithiazine-1. 1-dioxides (1a-e) with allylamine. Selective hydrazinolysis of the allylaminobenzodithiazines (2a-e) gave the appropriate 1-allyl 1-3-amino-2-(4-chloro-2-mercaptobenzenesulphonyl)guanidines (3a-e) in good yields. The reaction of 3a with dimethylsulphate under alkaline conditions provided the methylthio derivative 4. The structures of these compounds were confirmed on the basis of elemental analysis. spectral data (IR. H-1- and C-13-NMR) and X-ray analysis. Screening data indicated that the compounds 3a and 3d exhibited significant in vitro activities against numerous human tumour cell lines, whereas compounds 3b and 3c showed a moderate activity. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 38 条
  • [1] COMPARISON OF DIMENSIONS AND CONFORMATION OF SULFAGUANIDINE MOIETY IN SULFAGUANIDINE MONOHYDRATE AND TRANS-DICHLOROBIS(SULFAGUANIDINE)PALLADIUM(II)
    ALLEAUME, M
    GULKO, A
    HERBSTEIN, FH
    KAPON, M
    MARSH, RE
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1976, 32 (MAR15): : 669 - 682
  • [2] Artico M, 1996, FARMACO, V51, P305
  • [3] BOYD M R, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P652
  • [4] THE CRYSTAL STRUCTURE OF NITROGUANIDINE
    BRYDEN, JH
    BURKARDT, LA
    HUGHES, EW
    [J]. ACTA CRYSTALLOGRAPHICA, 1956, 9 (06): : 573 - 578
  • [5] BRZOZOWSKI Z, 1984, ACTA POL PHARM, V41, P5
  • [6] Brzozowski Z, 1997, Acta Pol Pharm, V54, P293
  • [7] Brzozowski Z, 1998, Acta Pol Pharm, V55, P233
  • [8] BRZOZOWSKI Z, 1984, ACTA POL PHARM, V41, P133
  • [9] Brzozowski Z, 1998, Acta Pol Pharm, V55, P473
  • [10] Brzozowski Z, 1998, Acta Pol Pharm, V55, P375